Laurent Van Lerberghe
Laurent Van Lerberghe  is a seasoned digital health investor and strategic leader with over 25 years of pharma C-suite experience, including transformative roles as Chief Strategy Officer at Sanofi and Commercial VP at Abbott. Throughout his career, Laurent has been a driving force in healthcare innovation, shaping the strategies of major corporations and delivering results across the US, Europe, and Asia. At Sanofi, he led pivotal initiatives, including the creation of the Gene Therapy Unit and orchestrating acquisitions that expanded the company’s footprint in oncology, immunology, and digital health, and raised Sanofi’s stock value to historic heights.
Company:KELES
At the heart of KELES’ mission is a commitment to pioneering today’s digital healthcare innovation across Europe.
The firm’s vision is to integrate traditional healthcare methodologies with revolutionary digital solutions—elevating patient care, advancing AI research and development, and transforming diagnostics.
KELES is uniquely positioned to access the best deals, enable scale-up, and maximise exit opportunities. With experience spanning from inception to exit, from investor to acquirer, the team understands both the economics and execution required to build lasting value.
